chr2:10580094:> Detail (hg19)

Information

Genome

Assembly Position
hg19 chr2:10,580,094-10,588,453
hg38 chr2:10,439,968-10,448,327 

HGVS

Type Transcript Protein
Summary

MGeND

Clinical significance
Variant entry
GWAS entry
Disease area statistics Show details

Frequency

[No Data.]

Prediction

[No Data.]

ClinVar

Clinical Significance
Review star [No Data.]
Show details
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
[No Data.]
DisGeNET
Score Disease name Description Source Pubmed Links
<0.001 squamous cell carcinoma NA BeFree Detail
0.002 Cardiovascular Diseases NA GAD Detail
0.002 Carotid Artery Diseases NA GAD Detail
<0.001 cerebral infarction NA BeFree Detail
<0.001 ulcerative colitis NA BeFree Detail
<0.001 Colonic Diseases NA BeFree Detail
0.121 Colonic Neoplasms NA BeFree,CTD_human Detail
<0.001 Colonic Polyps NA BeFree Detail
0.004 colorectal carcinoma NA BeFree Detail
0.128 Colorectal Neoplasms NA BeFree,CTD_human,GAD,LHGDN Detail
0.002 Coronary heart disease NA GAD Detail
<0.001 cystic fibrosis NA BeFree Detail
<0.001 Mental Depression NA BeFree Detail
<0.001 depressive disorder NA BeFree Detail
<0.001 Dwarfism NA BeFree Detail
<0.001 epilepsy NA BeFree Detail
<0.001 Esophageal Neoplasms NA BeFree Detail
<0.001 breast fibrocystic disease NA BeFree Detail
<0.001 gastritis NA BeFree Detail
<0.001 Gastritis, Atrophic NA BeFree Detail
<0.001 Glioma Recent research reported the visualization of CSCs in breast cancer and gliomas ... BeFree 25269542 Detail
<0.001 Hamartoma NA BeFree Detail
0.121 HIV Infections NA BeFree,CTD_human Detail
<0.001 ischemia NA BeFree Detail
<0.001 Kidney Failure, Chronic NA BeFree Detail
<0.001 Leishmaniasis, Visceral Leishmania donovani: impairment of the cellular immune response against recombin... BeFree 25449949 Detail
<0.001 leukemia NA BeFree Detail
<0.001 chronic lymphocytic leukemia NA BeFree Detail
<0.001 lymphoid leukemia NA BeFree Detail
<0.001 Myeloid Leukemia, Chronic NA BeFree Detail
<0.001 acute promyelocytic leukemia NA BeFree Detail
0.002 Liver neoplasms NA BeFree Detail
<0.001 lymphoma NA BeFree Detail
<0.001 Malignant neoplasm of stomach NA BeFree Detail
<0.001 melanoma NA BeFree Detail
0.003 meningioma NA BeFree,LHGDN Detail
0.002 multiple myeloma NA BeFree Detail
<0.001 Myeloproliferative disease NA BeFree Detail
<0.001 Myotonic dystrophy NA BeFree Detail
0.003 Neoplasm Metastasis NA BeFree,LHGDN Detail
0.002 Neoplasm Recurrence, Local NA GAD Detail
0.003 neuroblastoma Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits gly... BeFree 25415050 Detail
<0.001 osteosarcoma NA BeFree Detail
<0.001 Pancreatic Neoplasm NA BeFree Detail
0.120 papilloma NA BeFree,CTD_human Detail
<0.001 Peutz-Jeghers syndrome NA BeFree Detail
<0.001 plague NA BeFree Detail
0.001 Adenomatous Polyposis Coli NA BeFree Detail
0.001 polyps NA BeFree Detail
<0.001 Precancerous Conditions NA BeFree Detail
0.003 Prostatic Neoplasms NA BeFree,LHGDN Detail
<0.001 rhabdomyosarcoma NA BeFree Detail
<0.001 short bowel syndrome NA BeFree Detail
0.120 Skin Neoplasms NA BeFree,CTD_human Detail
0.003 Stomach Diseases NA BeFree,GAD Detail
<0.001 Cerebrovascular accident NA BeFree Detail
<0.001 African Trypanosomiasis NA BeFree Detail
<0.001 Chagas disease NA BeFree Detail
<0.001 Diffuse cutaneous leishmaniasis Our data implicate arginase I, ODC, PGE2, and TGF-β in the failure to mount an e... BeFree 25124926 Detail
<0.001 esophageal carcinoma NA BeFree Detail
<0.001 Encephalomyelitis, Western Equine NA BeFree Detail
<0.001 Malignant neoplasm of mouth NA BeFree Detail
<0.001 Tumor Progression NA BeFree Detail
0.003 Neuroendocrine Tumors NA BeFree,LHGDN Detail
<0.001 Lip and oral cavity carcinoma NA BeFree Detail
<0.001 Juvenile polyp NA BeFree Detail
<0.001 pancreatic carcinoma NA BeFree Detail
<0.001 Malignant neoplasm of lung NA BeFree Detail
<0.001 Liver and Intrahepatic Biliary Tract Carcinoma NA BeFree Detail
<0.001 Adenocarcinoma of pancreas NA BeFree Detail
<0.001 Multiple polyps NA BeFree Detail
<0.001 Malignant neoplasm of liver NA BeFree Detail
<0.001 Malignant neoplasm of pancreas NA BeFree Detail
<0.001 Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site NA BeFree Detail
0.003 Malignant neoplasm of prostate NA BeFree Detail
<0.001 Congenital Myotonic Dystrophy NA BeFree Detail
<0.001 hiv-infection/aids NA BeFree Detail
<0.001 Recurrent tumor NA BeFree Detail
<0.001 Malignant neoplasm of esophagus NA BeFree Detail
<0.001 Osteosarcoma of bone NA BeFree Detail
0.005 Carcinogenesis We have implicated polyamines, generated by the rate-limiting enzyme ornithine d... BeFree 25174398 Detail
0.003 prostate carcinoma NA BeFree Detail
<0.001 Myeloproliferative disease Critical roles of Myc-ODC axis in the cellular transformation induced by myelopr... BeFree 23300995 Detail
0.004 breast carcinoma NA BeFree Detail
<0.001 Carcinoma of lung NA BeFree Detail
<0.001 Chronic myeloproliferative disorder Critical roles of Myc-ODC axis in the cellular transformation induced by myelopr... BeFree 23300995 Detail
<0.001 Malignant neoplasm of gastrointestinal tract NA BeFree Detail
<0.001 Secondary malignant neoplasm of lymph node NA BeFree Detail
0.002 colon carcinoma NA BeFree Detail
0.001 stomach carcinoma NA BeFree Detail
0.003 Central neuroblastoma Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits gly... BeFree 25415050 Detail
<0.001 Middle Cerebral Artery Occlusion NA BeFree Detail
<0.001 gastritis h pylori NA BeFree Detail
<0.001 Adenomatous polyp of colon NA BeFree Detail
<0.001 Helicobacter pylori infection NA BeFree Detail
<0.001 Cerebral Ischemia NA BeFree Detail
0.002 coronary restenosis NA GAD Detail
<0.001 Chronic myeloproliferative disorder NA BeFree Detail
0.002 Adenoma of large intestine NA BeFree Detail
<0.001 Primary Carcinoma NA BeFree Detail
<0.001 Epithelioma NA BeFree Detail
<0.001 Hepatocarcinogenesis NA BeFree Detail
<0.001 Skin Carcinogenesis NA BeFree Detail
<0.001 Tumor Promotion NA BeFree Detail
0.010 colorectal cancer NA BeFree,GAD Detail
<0.001 Non-Malignant Ascites Adverse Event NA BeFree Detail
<0.001 Benign Prostatic Hyperplasia NA BeFree Detail
<0.001 Meningioma, benign, no ICD-O subtype NA BeFree Detail
<0.001 megalencephalic leukoencephalopathy with subcortical cysts Data on the relationship between ornithine decarboxylase and the cellular immune... BeFree 25449949 Detail
0.080 atrichia with papular lesions NA MGD Detail
0.002 liver carcinoma NA BeFree Detail
<0.001 Promyelocytic leukemia NA BeFree Detail
<0.001 aggressive cancer NA BeFree Detail
0.003 adenocarcinoma NA LHGDN Detail
0.006 adenoma NA BeFree,GAD Detail
<0.001 Alzheimer's disease Pharmacologic disruption of the arginine utilization pathway by an inhibitor of ... BeFree 25878270 Detail
<0.001 rheumatoid arthritis NA BeFree Detail
<0.001 Brain Diseases NA BeFree Detail
0.006 Malignant neoplasm of breast NA BeFree,GAD Detail
0.002 Malignant tumor of colon NA BeFree Detail
<0.001 Non-small cell lung carcinoma NA BeFree Detail
Annotation

Annotations

DescrptionSourceLinks
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Recent research reported the visualization of CSCs in breast cancer and gliomas using green fluoresc... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarb... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism i... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Our data implicate arginase I, ODC, PGE2, and TGF-β in the failure to mount an efficient immune resp... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
We have implicated polyamines, generated by the rate-limiting enzyme ornithine decarboxylase (ODC), ... DisGeNET Detail
NA DisGeNET Detail
Critical roles of Myc-ODC axis in the cellular transformation induced by myeloproliferative neoplasm... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Critical roles of Myc-ODC axis in the cellular transformation induced by myeloproliferative neoplasm... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism i... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Data on the relationship between ornithine decarboxylase and the cellular immune response in VL pati... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
Pharmacologic disruption of the arginine utilization pathway by an inhibitor of arginase and ornithi... DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail
NA DisGeNET Detail

Overlapped Transcript Coordinates

Gene Transcript ID Exon Number Chromosome Start Stop Type Amino Mutation Transcript Position Links

Overlapped Transcript

Gene Transcript ID Chromosome Start Stop Links
Gene
-
dbSNP
rs386626619 dbSNP
Genome
hg19
Position
chr2:10,580,094-10,588,453
Variant Type
snv
Genome browser